The Forbion Growth Opportunities Fund targets private growth capital, and select crossover and public investments, to support companies developing impactful new treatments in areas of high unmet need.
The Forbion Growth Opportunities investments focus on providing capital for clinical stage drug development, primarily as private growth capital, and selectively as crossover and public investments, where we see compelling potential for impactful products. By enabling access to significant capital for late-stage development, as well as hands-on engagement and strategic partnership, we support leading biotechs in Europe and US to develop groundbreaking therapies for pressing unmet medical needs.
